Literature DB >> 24590748

Clostridium difficile infection among children across diverse US geographic locations.

Joyanna M Wendt1, Jessica A Cohen, Yi Mu, Ghinwa K Dumyati, John R Dunn, Stacy M Holzbauer, Lisa G Winston, Helen L Johnston, James I Meek, Monica M Farley, Lucy E Wilson, Erin C Phipps, Zintars G Beldavs, Dale N Gerding, L Clifford McDonald, Carolyn V Gould, Fernanda C Lessa.   

Abstract

OBJECTIVE: Little is known about the epidemiology of Clostridium difficile infection (CDI) among children, particularly children ≤3 years of age in whom colonization is common but pathogenicity uncertain. We sought to describe pediatric CDI incidence, clinical presentation, and outcomes across age groups.
METHODS: Data from an active population- and laboratory-based CDI surveillance in 10 US geographic areas during 2010-2011 were used to identify cases (ie, residents with C difficile-positive stool without a positive test in the previous 8 weeks). Community-associated (CA) cases had stool collected as outpatients or ≤3 days after hospital admission and no overnight health care facility stay in the previous 12 weeks. A convenience sample of CA cases were interviewed. Demographic, exposure, and clinical data for cases aged 1 to 17 years were compared across 4 age groups: 1 year, 2 to 3 years, 4 to 9 years, and 10 to 17 years.
RESULTS: Of 944 pediatric CDI cases identified, 71% were CA. CDI incidence per 100,000 children was highest among 1-year-old (66.3) and white (23.9) cases. The proportion of cases with documented diarrhea (72%) or severe disease (8%) was similar across age groups; no cases died. Among the 84 cases interviewed who reported diarrhea on the day of stool collection, 73% received antibiotics during the previous 12 weeks.
CONCLUSIONS: Similar disease severity across age groups suggests an etiologic role for C difficile in the high rates of CDI observed in younger children. Prevention efforts to reduce unnecessary antimicrobial use among young children in outpatient settings should be prioritized.

Entities:  

Keywords:  Clostridium difficile; antimicrobial stewardship; community-associated; pediatric

Mesh:

Year:  2014        PMID: 24590748     DOI: 10.1542/peds.2013-3049

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  35 in total

Review 1.  Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics.

Authors:  Adam L Hersh; Jeffrey S Gerber; Lauri A Hicks; Andrew T Pavia
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-23       Impact factor: 3.164

Review 2.  Diagnosis of Clostridium difficile Infections in Children.

Authors:  Stella Antonara; Amy L Leber
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

3.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.

Authors:  Daniel E Freedberg; Esi S Lamousé-Smith; Jenifer R Lightdale; Zhezhen Jin; Yu-Xiao Yang; Julian A Abrams
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

Review 5.  Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

6.  Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

Authors:  T J Carlson; D Blasingame; A J Gonzales-Luna; F Alnezary; K W Garey
Journal:  Anaerobe       Date:  2019-12-19       Impact factor: 3.331

7.  Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children.

Authors:  Maribeth R Nicholson; Gerald T Van Horn; Yi-Wei Tang; Jan Vinjé; Daniel C Payne; Kathryn M Edwards; James D Chappell
Journal:  J Pediatr       Date:  2016-06-18       Impact factor: 4.406

8.  A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.

Authors:  James W Antoon; Margaret Hall; Diana Metropulos; Michael J Steiner; Ravi Jhaveri; Jacob A Lohr
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

9.  Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.

Authors:  A Lo Vecchio; L Lancella; C Tagliabue; C De Giacomo; S Garazzino; M Mainetti; L Cursi; E Borali; M V De Vita; E Boccuzzi; L Castellazzi; S Esposito; A Guarino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-30       Impact factor: 3.267

10.  Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis.

Authors:  Larry K Kociolek; Dale N Gerding; Robyn O Espinosa; Sameer J Patel; Stanford T Shulman; Egon A Ozer
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.